BioMed Research International / 2009 / Article / Tab 1

Research Article

Variable Increased Expression of Program Death-1 and Program Death-1 Ligands on Peripheral Mononuclear Cells Is Not Impaired in Patients with Systemic Lupus Erythematosus

Table 1

Comparisons of PD-1 and PD-1 ligands-expressing PBMC between SLE and normal controls.

CD3+T cellsCD19+B cellsCD14+ Monocytes

Normal ( ) Mean ± SD (%)SLE ) Mean ± SD (%)Normal ( ) Mean ± SD (%)SLE ( ) Mean ± SD (%)Normal ( ) Mean ± SD (%)SLE ( ) Mean ± SD (%)

PD-10.64 ± 0.531.52 ± 1.12*2.14 ± 1.675.11 ± 3.91*5.78 ± 5.177.28 ± 5.79
PD-L123.3 ± 8.0628.01 ± 12.8213.21 ± 7.6620.59 ± 10.24*96.66 ± 5.8596.83 ± 4.24
PD-L23.6 ± 2.523.79 ± 2.633.92 ± 2.959.59 ± 19.1572.12 ± 26.9284.78 ± 12.82*

* indicates statistically significant difference ( ).

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.